The rarity of malignant pheochromocytoma coupled with the lack of definitive predictors of malignancy and the variability of clinical course, poses a significant diagnostic and therapeutic challenge. Since data on treatment is so scarce, case reports are a valuable source of knowledge for clinicians. This case report describes the medical history of a woman, aged 51 at the time of initial diagnosis and adrenalectomy. Within over 5 years she presented with recurrent relapse of tumour in adrenal gland bed and multiple distant metastases to descending colon, abdominal wall, postoperative scars, and the peritoneum. Neither before diagnosis nor during the whole follow-up were symptoms associated with pheochromocytoma present. The treatment admin...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Catecholamine-secreting tumors occur with equal frequency in men and women, primarily in the fourth ...
AbstractPheochromocytomas are rare neuroendocrine tumors. Although predominantly occurring in the ad...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Background: Pheochromocytoma is a neuroendocrine tumor that predominantly presents with hypertension...
Pheochromocytoma is a rare catecholamine secreting tumor that are usually arise from adrenal medulla...
Background: Pheochromocytoma (PHEO) is a rare tumor of the adrenal medulla and sympathetic ganglion ...
Pheochromocytoma (PCC) is a tumor derived from adrenomedullary chromaffin cells. Prognosis of malign...
Pheochromocytoma is a rare benign tumor of the adrenal gland. A select few cases may be malignant, a...
Pheochromocytoma is a rare benign tumor of the adrenal gland. A select few cases may be malignant, a...
PURPOSE: We report herein 119 patients with pheochromocytoma at our institute over the last 23 years...
Background: Adrenal pheochromocytoma is potentially lethal if undetected and is associated with long...
Background: Malignant pheochromocytomas are rare. Many controversies still exists in clinical practi...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Catecholamine-secreting tumors occur with equal frequency in men and women, primarily in the fourth ...
AbstractPheochromocytomas are rare neuroendocrine tumors. Although predominantly occurring in the ad...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Background: Pheochromocytoma is a neuroendocrine tumor that predominantly presents with hypertension...
Pheochromocytoma is a rare catecholamine secreting tumor that are usually arise from adrenal medulla...
Background: Pheochromocytoma (PHEO) is a rare tumor of the adrenal medulla and sympathetic ganglion ...
Pheochromocytoma (PCC) is a tumor derived from adrenomedullary chromaffin cells. Prognosis of malign...
Pheochromocytoma is a rare benign tumor of the adrenal gland. A select few cases may be malignant, a...
Pheochromocytoma is a rare benign tumor of the adrenal gland. A select few cases may be malignant, a...
PURPOSE: We report herein 119 patients with pheochromocytoma at our institute over the last 23 years...
Background: Adrenal pheochromocytoma is potentially lethal if undetected and is associated with long...
Background: Malignant pheochromocytomas are rare. Many controversies still exists in clinical practi...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors and about 2-13% of PHEOs are malignant. Pre...
Catecholamine-secreting tumors occur with equal frequency in men and women, primarily in the fourth ...